Matches in Nanopublications for { ?s ?p "Some reduction in transactivation but, completely abolishes MAPK9-mediated activation. Abolishes MAPK9-mediated and greatly reduces adenovirus E1A-mediated transactivation; when associated with A-51 and A-53. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-51 and A-53." ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_P17544-2_MUTAGEN_101_101.RA4YC4U5D_qSoguH3jpTM1HHPI6uzv31WAdQxVTcU8u-E._1 comment "Some reduction in transactivation but, completely abolishes MAPK9-mediated activation. Abolishes MAPK9-mediated and greatly reduces adenovirus E1A-mediated transactivation; when associated with A-51 and A-53. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-51 and A-53." NX_P17544-2_MUTAGEN_101_101.RA4YC4U5D_qSoguH3jpTM1HHPI6uzv31WAdQxVTcU8u-E.assertion.
- NX_P17544-6_MUTAGEN_101_101.RAymemosID-J34Pp4cg-4ZnV7WNgmjwaWRgCq8cxIX5sY._1 comment "Some reduction in transactivation but, completely abolishes MAPK9-mediated activation. Abolishes MAPK9-mediated and greatly reduces adenovirus E1A-mediated transactivation; when associated with A-51 and A-53. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-51 and A-53." NX_P17544-6_MUTAGEN_101_101.RAymemosID-J34Pp4cg-4ZnV7WNgmjwaWRgCq8cxIX5sY.assertion.
- NX_P17544-1_MUTAGEN_112_112.RAllBd32SVYN0D-zcuXqysW9hZ1db6Tsxqd7kVG4bvYGg._1 comment "Some reduction in transactivation but, completely abolishes MAPK9-mediated activation. Abolishes MAPK9-mediated and greatly reduces adenovirus E1A-mediated transactivation; when associated with A-51 and A-53. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-51 and A-53." NX_P17544-1_MUTAGEN_112_112.RAllBd32SVYN0D-zcuXqysW9hZ1db6Tsxqd7kVG4bvYGg.assertion.
- NX_P17544-3_MUTAGEN_112_112.RAuzwY64KxxaTGIN3gxmA_1Cb-YAad_8Ivzyig9TEOf08._1 comment "Some reduction in transactivation but, completely abolishes MAPK9-mediated activation. Abolishes MAPK9-mediated and greatly reduces adenovirus E1A-mediated transactivation; when associated with A-51 and A-53. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-51 and A-53." NX_P17544-3_MUTAGEN_112_112.RAuzwY64KxxaTGIN3gxmA_1Cb-YAad_8Ivzyig9TEOf08.assertion.
- NX_P17544-4_MUTAGEN_101_101.RAq5Th7atVXOK0VY7jjOii6ksxt0tnNyCHWsHzPq0zSjo._1 comment "Some reduction in transactivation but, completely abolishes MAPK9-mediated activation. Abolishes MAPK9-mediated and greatly reduces adenovirus E1A-mediated transactivation; when associated with A-51 and A-53. Abolishes adenovirus 2 E1A-mediated transactivation; when associated with A-14; A-51 and A-53." NX_P17544-4_MUTAGEN_101_101.RAq5Th7atVXOK0VY7jjOii6ksxt0tnNyCHWsHzPq0zSjo.assertion.